Novartis has agreed to sell its entire 70.68% stake in Novartis India to a private equity consortium for about $159 million, marking its exit from the Indian listed entity as part of a broader global restructuring strategy. The Mumbai-based company primarily sells medicines in India and does not operate manufacturing facilities in the country. The […]Continue Reading
